Blood test identifies brain damage from concussion in ice hockey
News Mar 14, 2014
Half way into last year's season, 35 of 288 players in the Swedish Hockey League had already had a concussion. Researchers at Sahlgrenska Academy, who surveyed all of the players in the league's 12 clubs, have now developed a method that can show just an hour after the injury how severe the concussion is, if there is a risk of long-term symptoms and about when the player can return to the game.
Between September and December of the 2012/2013 season alone, 35 of 288 players in the Swedish Hockey League (SHL) had had a concussion -- in three cases, it was so severe that the player was knocked unconscious.
These were the findings of researchers at Sahlgrenska Academy at the University of Gothenburg, who monitored and examined all of the players in the Sweden's top hockey league in cooperation with Luleå University of Technology.
The goal of the unique study was to find safer methods of diagnosing sports-related brain injuries, and to obtain a better basis for decisions about when the player can return to the game.
In the study, the players who had a concussion were asked to provide repeated blood samples, directly after the concussion and during the ensuing days. The results were compared with the pre-season samples from two full teams.
This way, Professor Henrik Zetterberg and his colleagues could show that a special nerve cell protein, called tau, at elevated levels in the blood is a marker of concussion.
By measuring the tau levels in a regular blood test, the researchers could say how severe the concussion was just one hour after the injury, and with a high level of certainty could predict which players would have long-term symptoms and thereby needed to rest longer.
"In ice hockey and other contact sports, repeated concussions are common, where the brain has not finished healing after the first blow. This kind of injury is particularly dangerous, but there have not been any methods for monitoring how a concussion in an athlete heals," says Henrik Zetterberg.
Henrik Zetterberg is among the world's leading brain researchers and has conducted research on concussions in sports for many years and in numerous studies. According to Zetterberg, the new findings are not only relevant to ice hockey, but to all sports where there is a risk of head injuries.
"In contact sports like ice hockey, boxing and American football, concussions are a growing international problem. The stakes for the individual athlete are high, and the list of players forced to quit with life-long injury is getting ever longer," says Henrik Zetterberg.
"We hope that this method will be developed into a clinical tool for club physicians and others in sports medicine, and is used as a basis for the decision on how long the player should rest after a blow to the head," says Henrik Zetterberg. "It could even be used in general in emergency medical care to diagnose brain damage from concussions regardless of how they happened."
The study was conducted in cooperation with researchers at the Luleå University of Technology, Sahlgrenska University Hospital and the US biotech firm Quanterix Corporation.
Yelverton Tegner, a researcher at Luleå University of Technology and also physician for the Swedish national women's football team, is positive:
"Our goal is to have a working kit that can be used for diagnostics in hospitals, and perhaps also at rink side in stadiums immediately when someone got a concussion."
Note: Material may have been edited for length and content. For further information, please contact the cited source.
Pashtun Shahim, Yelverton Tegner, David H. Wilson, Jeffrey Randall, Tobias Skillbäck, David Pazooki, Birgitta Kallberg, Kaj Blennow, Henrik Zetterberg. Blood Biomarkers for Brain Injury in Concussed Professional Ice Hockey Players. Science, Published March 13 2014. doi: 10.1001/jamaneurol.2014.367
Molecules in Spit Could Help Diagnose ConcussionsNews
Diagnosing a concussion can sometimes be a guessing game, but clues taken from small molecules in saliva may be able to help diagnose and predict the duration of concussions in children, according to Penn State College of Medicine researchers.READ MORE
Elpis BioMed Closes Funding Round to Commercialise Novel Technology Platform for Generating Human Cell TypesNews
New Cambridge spin-out company commercialises disruptive technology that enables rapid generation of pure and consistent batches of human cell types. Geographically diversified, top-tier investor team includes key industry leaders to support early company development.READ MORE
Study: Non-fearful social withdrawal linked positively to creativityNews
Newly published research by a University at Buffalo psychologist suggests that not all forms of social withdrawal are detrimental.READ MORE